Marval Biosciences' Series B Round

Marval Biosciences raised a round of funding on October 21, 2009.

Marval Biosciences is an early stage company, developing contrast agents for use in X-ray and Computed Tomography (CT) Imaging. Marval's lead candidate, NCTX, targets cardiovascular imaging.…

Articles about Marval Biosciences' Series B Round: